FATE – fate therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Fate Therapeutics, Inc. (NASDAQ:FATE) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance]
Fate Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
Form SC 13G/A FATE THERAPEUTICS INC Filed by: Point72 Asset Management, L.P.
Form 10-Q FATE THERAPEUTICS INC For: Sep 30
Form 8-K FATE THERAPEUTICS INC For: Nov 12
Form SC 13G/A FATE THERAPEUTICS INC Filed by: BlackRock, Inc.
Form SC 13G/A FATE THERAPEUTICS INC Filed by: Boxer Capital Management, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.